GlaxoSmithKline Biologicals

FDA inspection history in Saint-Amand Les Eaux, France, 2022 to 2024

2
Form 483s

Every document, by year

  • Form 483

2022: one Form 483; 2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2022–24Two Form 483s, at Saint-Amand Les Eaux, France.
  2. 2024The longest 483 on file: 3 observations over 6 pages at Saint-Amand Les Eaux, France.

Cited most

Across all GlaxoSmithKline Biologicals observations on file

The complete GlaxoSmithKline Biologicals file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2024-03-12483 Form 483$99
2022-09-13483 Form 483$99

Investigators on these documents

Latorie S. Jones (1)

FEI number 3014752610 · most recent document Mar 12, 2024

About GlaxoSmithKline Biologicals

How many FDA Form 483s has GlaxoSmithKline Biologicals received?

FDA Intel has 2 Form 483s on file for GlaxoSmithKline Biologicals; the most recent is dated Mar 12, 2024.

When was GlaxoSmithKline Biologicals last inspected by FDA?

The most recent FDA inspection document on file for GlaxoSmithKline Biologicals is a Form 483 dated Mar 12, 2024, for the site in Saint-Amand Les Eaux, France.

What did FDA cite at GlaxoSmithKline Biologicals?

The regulations cited most in the observations on file for GlaxoSmithKline Biologicals are 21 CFR 211.67(b)(6) (Equipment cleaning and maintenance), 2 times; 21 CFR 211.170(b) (Reserve samples), 1 time; 21 CFR 211.192 (Production record review), 1 time.